IHM
SAGE

Iguana Healthcare Management’s Sage Therapeutics SAGE Stock Holding History

Iguana Healthcare Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-50,000
Closed -$2.92M – 82
2015
Q4 		$2.92M Buy
50,000
+10,000
+25% +$495K 0.96% 29
2015
Q3 		$1.69M Buy
+40,000
New +$2.47M 0.67% 42

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Iguana Healthcare Management's SAGE Position: Q1 2016 in Review

Iguana Healthcare Management sold out of Sage Therapeutics (SAGE) in Q1 2016, closing a stake of 50,000 shares — an estimated $2.92M sold.

Iguana Healthcare Management first reported a position in SAGE in Q3 2015 and held it in 2 quarters. The position peaked at $2.92M in Q4 2015. 144 funds tracked by Wall St. Rank hold SAGE as of Q1 2016.

  • Iguana Healthcare Management reported no remaining Sage Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 50,000 Sage Therapeutics shares in Q1 2016, an estimated $2.92M.
  • Iguana Healthcare Management first reported a position in Sage Therapeutics in Q3 2015 and held it in 2 quarters.
  • Iguana Healthcare Management's Sage Therapeutics position peaked at $2.92M in Q4 2015.
  • 144 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2016.

Based on Iguana Healthcare Management's 13F filing for Q1 2016, filed 17 May 2016.